These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M, UPLIFT Study Investigators. N Engl J Med; 2008 Oct 09; 359(15):1543-54. PubMed ID: 18836213 [Abstract] [Full Text] [Related]
6. Absence of electrocardiographic findings and improved function with once-daily tiotropium in patients with chronic obstructive pulmonary disease. Covelli H, Bhattacharya S, Cassino C, Conoscenti C, Kesten S. Pharmacotherapy; 2005 Dec 09; 25(12):1708-18. PubMed ID: 16305289 [Abstract] [Full Text] [Related]
7. Changes in lung function and health status in patients with COPD treated with tiotropium or salmeterol plus fluticasone. Kurashima K, Hara K, Yoneda K, Kanauchi T, Kagiyama N, Tokunaga D, Takayanagi N, Ubukata M, Sugita Y. Respirology; 2009 Mar 09; 14(2):239-44. PubMed ID: 19210650 [Abstract] [Full Text] [Related]
12. Concomitant treatment with nebulized formoterol and tiotropium in subjects with COPD: a placebo-controlled trial. Tashkin DP, Littner M, Andrews CP, Tomlinson L, Rinehart M, Denis-Mize K. Respir Med; 2008 Apr 09; 102(4):479-87. PubMed ID: 18258423 [Abstract] [Full Text] [Related]
15. COPD in young patients: a pre-specified analysis of the four-year trial of tiotropium (UPLIFT). Morice AH, Celli B, Kesten S, Lystig T, Tashkin D, Decramer M. Respir Med; 2010 Nov 09; 104(11):1659-67. PubMed ID: 20724131 [Abstract] [Full Text] [Related]
17. [A randomized, double-blind, placebo-control study of once-daily inhaled tiotropium in chronic obstructive pulmonary disease]. Yin KS, Zhang DP, Shi Y, Sun LH, Min R, Xiao YL, Xia XR, Tan Y, Fu WZ. Zhonghua Jie He He Hu Xi Za Zhi; 2010 Jul 09; 33(7):519-23. PubMed ID: 20979799 [Abstract] [Full Text] [Related]
18. Additive effects of transdermal tulobuterol to inhaled tiotropium in patients with COPD. Ichinose M, Seyama K, Nishimura M, Fukuchi Y, Nagai A, Mishima M, Kubo K, Beta-2 Agonist Research and Evaluation Committee in COPD (BAREC) Study Group. Respir Med; 2010 Feb 09; 104(2):267-74. PubMed ID: 19875277 [Abstract] [Full Text] [Related]